The SOX10 promoter has previously been shown to be epigenetically silenced in human gastric cancers and metastatic melanoma [24–26], the basal level of Sox10 expression is low in vitro, we hypothesized that Sox10 gene induction could be due to gene demethylation in SLK-/- NDL cells. The gene discussed is SOX10; the disease is metastatic melanoma.